Results 251 to 260 of about 346,103 (330)

Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute myeloid leukemia (AML) comprises 32% of adult leukemia cases, with a 5‐year survival rate of only 20–30%. Here, the immunophenotypic landscape of this heterogeneous malignancy is explored in a single‐center cohort using a novel quantitative computational pipeline.
Artuur Couckuyt   +10 more
wiley   +1 more source

Update on preclinical models of cancer therapy‐related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio‐Oncology, and the ESC Working Group on Cellular Biology of the Heart

open access: yesEuropean Journal of Heart Failure, EarlyView.
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the ...
Alessandra Ghigo   +22 more
wiley   +1 more source

Targeting PR1 in myeloid leukemia

open access: yesOncotarget, 2017
Gheath Alatrash   +2 more
openaire   +3 more sources

<i>Pneumocystis jirovecii</i> Pneumonia as an Unusual Presentation of De Novo Acute Myeloid Leukemia. [PDF]

open access: yesOpen Respir Arch
Briones Alvarado SI   +4 more
europepmc   +1 more source

<i>CEBPA</i>-associated familial acute myeloid leukemia mimicking Werner syndrome: a case report. [PDF]

open access: yesFront Genet
Demaret T   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy